Rosa Di Noto

CD56 Expression Is an Indicator of Poor Clinical Outcome in Patients With Acute Promyelocytic Leukemia Treated With Simultaneous All-Trans-Retinoic Acid and Chemotherapy

Felicetto Ferrara, Fortunato Morabito, Bruno Martino et al. · Journal of Clinical Oncology · 2000 · 168 citations

Medicine, Hematology, Oncology +15

Novel Synthetic, Salt-Resistant Analogs of Human Beta-Defensins 1 and 3 Endowed with Enhanced Antimicrobial Activity

Olga Scudiero, Stefania Galdiero, Marco Cantisani et al. · Antimicrobial Agents and Chemotherapy · 2010 · 105 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo

Marica Gemei, Peppino Mirabelli, Rosa Di Noto et al. · Cancer · 2012 · 61 citations

Medicine, Cell Biology, Oncology +16

Protein cross‐talk in <scp>CD</scp>133+ colon cancer cells indicates activation of the <scp>W</scp>nt pathway and upregulation of <scp>SR</scp>p20 that is potentially involved in tumorigenicity

Claudia Corbo, Stefania Orrù, Marica Gemei et al. · PROTEOMICS · 2012 · 55 citations

Medicine, Cell Biology, Oncology +17

Stem cell factor receptor (c‐kit, CD117) is expressed on blast cells from most immature types of acute myeloid malignancies but is also a characteristic of a subset of acute promyelocytic leukaemia

Rosa Di Noto, Catia Lo Pardo, Ettore Mariano Schiavone et al. · British Journal of Haematology · 1996 · 52 citations

Medicine, Hematology, Oncology +12